Absolutely correct nothing is going to move this baby until proven revenue has been booked. You can talk as much as you want about full GMP, distribution deals, purchase of land in Malta, RMIT and Sydney research programs, development of productive capacity, all the diseases under the sun that MM is a cure for, the potential and the promise of great things to come, valuation estimates based on pure speculation and chartist theory rubbish etc but nothing is going to move this like booked revenue will. This is why the SP moved on the Varmco deal and why the market is a lot more cautious now about "expectations of receiving $1 mio in the next month" rhetoric.Some posters may have written this off against the expectation of far bigger revenue flows to come but to me the varmco deal is symptomatic of deeper issues at BOD level.
